Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New vaccine slashes chance of melanoma patients’ tumors returning, study shows

Personalized Moderna and Merck vaccine, called intismeran, was made with same Nobel Prize-winning mRNA technology behind COVID-19 vaccines

New vaccine slashes chance of melanoma patients’ tumors returning, study shows

We haven't written up this one. The Times of Israel has the full story — the link below goes straight to it.

Read the original at timesofisrael.com →

More in Health & Medicine

More from Sunday 25 October →